Vera Therapeutics Inc
NASDAQ:VERA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vera Therapeutics Inc
NASDAQ:VERA
|
US |
|
Value Line Inc
NASDAQ:VALU
|
US |
|
O
|
Orangekloud Technology Inc
NASDAQ:ORKT
|
SG |
|
8
|
888 Holdings PLC
OTC:EIHDF
|
GI |
|
Morella Corporation Ltd
ASX:1MC
|
AU |
|
H
|
Hi Sun Technology (China) Ltd
XBER:HSUB
|
HK |
|
Prairie Provident Resources Inc
TSX:PPR
|
CA |
|
Freelancer Ltd
ASX:FLN
|
AU |
|
B
|
BurTech Acquisition Corp
NASDAQ:BRKH
|
US |
|
Gap Inc
NYSE:GAP
|
US |
Wall Street
Price Targets
VERA Price Targets Summary
Vera Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VERA
is 79.72 USD
with a low forecast of 35.35 USD and a high forecast of 115.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VERA's stock price target?
Price Target
79.72
USD
According to Wall Street analysts, the average 1-year price target for
VERA
is 79.72 USD
with a low forecast of 35.35 USD and a high forecast of 115.5 USD.